Honey At Rigel Pharmaceuticals (RIGL) Is Worth Your Money

Rigel Pharmaceuticals (NASDAQ:RIGL) price on Wednesday, May 09, fall -16.61% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.99.

A look at the stock’s price movement, the close in the last trading session was $1.19. Turning to its 52-week performance, $1.96 and $0.71 were the 52-week high and 52-week low respectively. Overall, RIGL moved -20.62% over the past month.

Rigel Pharmaceuticals’s market cap currently stands at around $174.03 million.

Analysts have a consensus estimate of 33.1M for the company’s revenue for the quarter, with a low and high estimate of 31.56M and 34.2M respectively. The average forecast suggests up to a 23.10% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 148.99M, representing a 27.50% jump on that reported in the last financial year.

Turning to the stock’s technical picture we see that short term indicators suggest on average that RIGL is a 100% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.

RIGL’s current price about -12.75% and -24.29% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 34.03, while 7-day volatility ratio is 7.91% and 6.21% in the 30-day chart. Further, Rigel Pharmaceuticals (RIGL) has a beta value of 1.08, and an average true range (ATR) of 0.08.

If we refocus on Rigel Pharmaceuticals (NASDAQ:RIGL), historical trading data shows that trading volumes averaged 1.49 million over the past 3 months. The company’s latest data on shares outstanding shows there are 174.83 million shares.

The 1.90% of Rigel Pharmaceuticals’s shares are in the hands of company insiders while institutional holders own 60.79% of the company’s shares. Current price change has pushed the stock -31.57% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the RIGL stock continues to rise going into the next quarter.

Most Popular